Invention Application
- Patent Title: NOVEL VIRAL REPLICATION INHIBITORS
-
Application No.: US16798859Application Date: 2020-02-24
-
Publication No.: US20200223845A1Publication Date: 2020-07-16
- Inventor: Dorothée Bardiot , Gunter Carlens , Kai Dallmeier , Suzanne Kaptein , Mohamed Koukni , Arnaud Marchand , Johan Neyts , Wim Smets
- Applicant: Katholieke Universiteit Leuven
- Applicant Address: BE Leuven
- Assignee: Katholieke Universiteit Leuven
- Current Assignee: Katholieke Universiteit Leuven
- Current Assignee Address: BE Leuven
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3ba35c8a
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D401/14 ; C07D405/14 ; C07D413/14 ; C07D223/04 ; C07D231/12 ; C07D333/22 ; C07D401/04 ; C07D401/06 ; C07D403/04 ; C07D405/04 ; C07D405/06 ; C07D409/04 ; C07D409/06 ; C07D409/14 ; C07D413/04 ; C07D413/06 ; C07D417/04 ; C07D417/06 ; C07D417/12 ; C07D417/14 ; C07D261/08 ; C07D207/06 ; C07D265/30 ; C07D267/10 ; C07D275/02 ; C07D498/04 ; C07D279/12 ; A61K31/415 ; C07D409/12 ; A61K31/34 ; A61K31/381 ; A61K31/40 ; C07D207/323 ; C07D403/06 ; C07D405/12 ; C07D407/06 ; C07D271/04 ; C07D285/06 ; A61K31/4439 ; C07D403/12 ; C07D243/06 ; A61K31/437 ; C07D211/06 ; A61K45/06 ; C07D513/04 ; C07D407/04 ; C07D307/46 ; C07D207/335 ; C07D211/16 ; C07D241/04 ; C07D243/08 ; C07D263/32 ; C07D271/08 ; C07D277/28 ; C07D285/10 ; C07D307/52 ; C07D413/12 ; C07D487/04

Abstract:
The present invention relates to a series of novel compounds, methods to prevent or treat viral infections in animals by using the novel compounds and to said novel compounds for use as a medicine, more preferably for use as a medicine to treat or prevent viral infections, particularly infections with RNA viruses, more particularly infections with viruses belonging to the family of the Flaviviridae, and yet more particularly infections with the Dengue virus. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of viral infections. The invention also relates to processes for preparation of the compounds.
Public/Granted literature
- US11566025B2 Viral replication inhibitors Public/Granted day:2023-01-31
Information query